🕵️ Femasys Inc ($FEMY)
SEC insider & ownership activity, last 12 months · CIK 1339005 · every row links its SEC filing
Insiders were quiet over the last 12 months – no open-market buys or sells. Dauntless Investment Group, LLC added 5.4% → 9.9%; Chernett Jorey added 6.2% → 9.3%. One red-flag 8-K in the window: Delisting notice (3.01), Jan 13, 2026.
Insider flow
0 buyers, $0 (0 lots) · 0 sellers, $0 (0 lots)
No open-market insider transactions in the last 12 months.
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Alumni Capital LP | 10.0% | 13G | Sep 4, 2025 | filing ↗ | |
| Alumni Capital GP LLC | 10.0% | 13G | Sep 4, 2025 | filing ↗ | |
| Ashkan Mapar | 10.0% | 13G | Sep 4, 2025 | filing ↗ | |
| Dauntless Investment Group, LLC | 9.9% | 13G | Nov 14, 2025 | filing ↗ | |
| Chernett Jorey | 9.3% | 13G | Aug 5, 2025 | filing ↗ | |
| Pharmacyte Biotech, Inc. | 7.9% | 13G | Mar 18, 2026 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Shareholder vote (5.07) | Jun 24, 2026 | filing ↗ |
| Other events (8.01) | Jun 23, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 23, 2026 | filing ↗ |
| Material Modifications to Rights of Security Holders (3.03) | Jun 5, 2026 | filing ↗ |
| Charter/bylaw changes (5.03) | Jun 5, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 5, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jun 4, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | May 13, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 13, 2026 | filing ↗ |
| Earnings (2.02) | May 8, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 8, 2026 | filing ↗ |
| Shareholder vote (5.07) | Apr 29, 2026 | filing ↗ |
| Earnings (2.02) | Mar 31, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 31, 2026 | filing ↗ |
| Officer/director changes (5.02) | Mar 30, 2026 | filing ↗ |
| Other events (8.01) | Mar 30, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 30, 2026 | filing ↗ |
| Material agreement (1.01) | Mar 17, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Mar 17, 2026 | filing ↗ |
| Officer/director changes (5.02) | Mar 17, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 17, 2026 | filing ↗ |
| Delisting notice (3.01) | Jan 13, 2026 | filing ↗ |
| Other events (8.01) | Dec 23, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 23, 2025 | filing ↗ |
| Other events (8.01) | Dec 18, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 18, 2025 | filing ↗ |
| Earnings (2.02) | Nov 14, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 14, 2025 | filing ↗ |
| Other events (8.01) | Nov 10, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 10, 2025 | filing ↗ |